Progress in brain targeting drug delivery system by nasal route

    loading  Checking for direct PDF access through Ovid

Abstract

The blood–brain barrier (BBB) restricts the transport of potential therapeutic moieties to the brain. Direct targeting the brain via olfactory and trigeminal neural pathways by passing the BBB has gained an important consideration for delivery of wide range of therapeutics to brain. Intranasal route of transportation directly delivers the drugs to brain without systemic absorption, thus avoiding the side effects and enhancing the efficacy of neurotherapeutics. Over the last several decades, different drug delivery systems (DDSs) have been studied for targeting the brain by the nasal route. Novel DDSs such as nanoparticles (NPs), liposomes and polymeric micelles have gained potential as useful tools for targeting the brain without toxicity in nasal mucosa and central nervous system (CNS). Complex geometry of the nasal cavity presented a big challenge to effective delivery of drugs beyond the nasal valve. Recently, pharmaceutical firms utilized latest and emerging nasal drug delivery technologies to overcome these barriers. This review aims to describe the latest development of brain targeted DDSs via nasal administration.

Chemical compounds studied in this article:

Carbopol 934p (PubChem CID: 6581)

Chemical compounds studied in this article:

Carboxy methylcellulose (PubChem CID: 24748)

Chemical compounds studied in this article:

Penetratin (PubChem CID: 101111470)

Chemical compounds studied in this article:

Poly lactic-co-glycolic acid (PubChem CID: 23111554)

Chemical compounds studied in this article:

Tween 80 (PubChem CID: 5284448)

Related Topics

    loading  Loading Related Articles